End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
29.76 CNY | -0.13% | +1.60% | +9.25% |
May. 09 | Pacific Shuanglin Bio-pharmacy Subsidiary Gets Plasmapheresis License | MT |
Apr. 26 | Pacific Shuanglin Bio-pharmacy Co., LTD Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+9.25% | 3.01B | |
-2.61% | 88.47B | |
+3.82% | 40.71B | |
-13.92% | 32.43B | |
+51.77% | 24.28B | |
-15.25% | 15.52B | |
-39.93% | 12.17B | |
-9.08% | 12B | |
-14.80% | 12.01B | |
+6.74% | 8.87B |
- Stock Market
- Equities
- 000403 Stock
- News Pacific Shuanglin Bio-pharmacy Co., LTD
- Pacific Shuanglin Bio-pharmacy Unit Gets Nod to Trial Human Coagulation Factor IX